Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00858221 · ClinicalTrials.gov registry record
Association of Genes to Resistance to Weight Loss in Obese Patients
A clinical trial of Obesity and Metabolic Syndrome, sponsored by Interleukin Genetics.
- Completed
- Registry status
- 824
- Enrollment target
- 1
- Study location
NCT00858221: Completed study of Obesity and Metabolic Syndrome, sponsored by Interleukin Genetics.
NCT00858221 is a study of Obesity and Metabolic Syndrome that has completed, run by Interleukin Genetics. The registered enrollment target is 824 participants, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00858221, a study of Obesity and Metabolic Syndrome, has completed, sponsored by Interleukin Genetics.
- COMPLETED
- Registry status
- 824 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this study is to determine whether variations in the perilipin, and several other, genes would be a useful tool for physicians who are caring for morbidly obese patients to guide therapy. The main hypotheses to be tested is that sequence variations (polymorphisms) in the perilipin gene and several other obesity-related genes are associated with resistance to weight loss for obese individuals on energy restricted diets, potentially playing a role in the development of obesity related complications.
Conditions Studied
Study Locations (1)
Pennsylvania
- Geisinger Health System - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 824 participants |
| Start Date | 2008-08 |
| Est. Completion | 2009-07 |
What the finished NCT00858221 record still lists
NCT00858221 is an observational study that tracks outcomes without assigning an intervention. The registered 824 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 818-participant average among 1,053 other Obesity trials with a reported enrollment target.
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 0 interventions.
NCT00858221 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00858221 about?
NCT00858221 is a clinical study titled "Association of Genes to Resistance to Weight Loss in Obese Patients". The overall goal of this study is to determine whether variations in the perilipin, and several other, genes would be a useful tool for physicians who are caring for morbidly obese patients to guide therapy. The main hypotheses to be tested is that sequence variations (polymorphisms) in the perilip...
What is the current status of trial NCT00858221?
This trial is currently completed. The enrollment target is 824 participants. The study started on 2008-08. Estimated completion is 2009-07.
What conditions does trial NCT00858221 study?
This clinical trial studies the following conditions: Obesity, Metabolic Syndrome, Dyslipidemia.
Who is sponsoring clinical trial NCT00858221?
This trial is sponsored by Interleukin Genetics, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00858221 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00858221's enrollment target sits among peer trials
824 89th of 1053 higher than 965 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06944509 · 824 participants · NA
RADIQAL Study (Radiation Dose and Image Quality Trial)
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- NCT07102641 · 825 participants · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
- NCT07318077 · 825 participants · NA
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia